Prevalence of Pressure Ulcers Among Critically Ill Patients and Factors Associated With Their Occurrence in the ICU
PRESSURE
1 other identifier
observational
1,228
1 country
60
Brief Summary
The prevalence of and risk factors for pressure ulcers (PUs) in critically ill patients have been poorly studied. The main objective of this study was to describe the prevalence of PUs in critically ill patients. Secondary objectives were to describe PUs, means of prevention of PUs, and factors associated with occurrence of PUs in the ICU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Shorter than P25 for all trials
60 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
April 8, 2019
CompletedFirst Posted
Study publicly available on registry
April 11, 2019
CompletedApril 11, 2019
April 1, 2019
Same day
April 8, 2019
April 10, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Pressure Ulcer Presence on the study day
Presence (1) or absence (0) of pressure ulcer (however grade of pressure ulcer) during the study period which is a 1 Day Study Prevalence
Through study completion, an average of 1 day
Secondary Outcomes (2)
Grade of Pressure Ulcer on the study day
Through study completion, an average of 1 day
Area of Pressure Ulcer on the study day
Through study completion, an average of 1 day
Interventions
Patient was evaluated according to presence of pressur ulcer or not
Eligibility Criteria
Patient in Critical Care during study day.
You may qualify if:
- hospitalization in the ICU
- age ≥ 18 years.
- \- refusal to participate in the study by the patient or by the patient's family when the patient was unable to consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (60)
Hôpital Saint-Esprit
Agen, 47923, France
CHU d'Angers
Angers, 49000, France
Hopital Privé d'Antony
Antony, 92166, France
Hopital Mercy
Ars-Laquenexy, 57245, France
Hopital Nord Franche Comté
Belfort, 90015, France
Hopital Avicenne
Bobigny, 93000, France
CHU Pellegrin
Bordeaux, 33000, France
Hopital St-Andre
Bordeaux, 33075, France
Hopital Ambroise Pare
Boulogne-Billancourt, 92100, France
HIA Clermont Tonnerre
Brest, 29240, France
Hopital Antoine Beclere
Clamart, 92140, France
HIA Percy
Clamart, 92190, France
Hopital Louis Mourier
Colombes, 92700, France
Groupe Hospitalier Sud Ile de France
Corbeil-Essonnes, 91100, France
Clinique des Cèdres
Cornebarrieu, 31700, France
CHU Henri Mondor
Créteil, 94010, France
CHU Dijon Bourgogne
Dijon, 21709, France
Hopital Simone Veil
Eaubonne, 95600, France
Hopital Raymond Poincare
Garches, 92380, France
CHU Grenoble Alpes
Grenoble, 38700, France
Grand Hopital de l'Est Francilien
Jossigny, 77600, France
CHU Réunion Saint Pierre
La Réunion, 97400, France
CHU Kremlin-Bicetre
Le Kremlin-Bicêtre, 94270, France
Hopital Roger Salengro
Lille, 59037, France
HIA Desgenettes Lyon
Lyon, 69003, France
Groupe Hospitalier Edouard Herriot
Lyon, 69437, France
Hopital Francois Quesnay
Mantes-la-Jolie, 78200, France
Hopital Européen Marseille
Marseille, 13003, France
CHU Marseille Hopital Nord
Marseille, 13015, France
Hopital de la Timone
Marseille, 13385, France
Hopital Notre-Dame de Bon Secours
Metz, 57038, France
GHIRM
Montfermeil, 93370, France
CHU Lapeyronie
Montpellier, 34090, France
CHU Nancy
Nancy, 54035, France
CHU Nantes
Nantes, 44000, France
Hopital Laennec
Nantes, 44035, France
Hopital l'Archet
Nice, 06202, France
CHU Nimes
Nîmes, 30029, France
Hopital St Louis
Paris, 75010, France
GH Diaconnesses Croix Saint Simon
Paris, 75012, France
La Pitié Salpetriere
Paris, 75013, France
Cochin
Paris, 75014, France
Institut Mutualiste Montsouris
Paris, 75014, France
CHU Necker Enfants Malades
Paris, 75015, France
CHU Robert Debré
Paris, 75015, France
HEGP
Paris, 75015, France
Hopital Tenon
Paris, 75020, France
CHU Poitiers
Poitiers, 86021, France
Hopital Privé Claude Galien
Quincy-sous-Sénart, 91480, France
Hopital Delafontaine
Saint-Denis, 93200, France
Clinique de l'Union
Saint-Jean, 31240, France
HIA Béjin
Saint-Mandé, 94160, France
Hopital Saint Clair
Sète, 34200, France
CHU Strasbourg
Strasbourg, 67200, France
CHU Toulouse Rangueil
Toulouse, 31400, France
Hopital Privé du Vert Galan
Tremblay-en-France, 93290, France
Hopital Jean Bernard
Valenciennes, 59322, France
Institut Gustave Roussy
Villejuif, 94805, France
HIA Robert Pique
Villenave-d'Ornon, 33140, France
Hopital Privé du Val d'Yerres
Yerres, 91330, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gael Piton, MD, PhD
French Intensive Care Society
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2019
First Posted
April 11, 2019
Study Start
June 1, 2017
Primary Completion
June 1, 2017
Study Completion
December 1, 2017
Last Updated
April 11, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share